CompletedNot Applicable

Prospective, Monocentric, Interventional Study on Spontaneous Vaginal Clearance of Mycoplasma Genitalium

France69 participantsStarted 2021-04-05

Plain-language summary

It is a prospective, monocentric, interventional study on spontaneous vaginal clearance of Mycoplasma genitalium. The main objective is to evaluate the spontaneous vaginal clearance of M. genitalium in patients coming to perform a voluntary termination of pregnancy at the University Hospital of Bordeaux at 9 weeks after a vaginal sample positive for M. genitalium

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient selected during the first consultation, pre-abortion, and having a vaginal swab positive to M. genitalium. * Patient hospitalized for an abortion at the University Hospital of Bordeaux. * An affiliated patient or beneficiary of a social security system. * Signing free and informed consent. Exclusion criteria: * Patient with vaginal co-infection with C. trachomatis. * Patient with symptoms of high genital infection. * Taking fluoroquinolones, macrolides or tetracyclines within 21 days of inclusion. * Patient under legal protection.

What they're measuring

clearance at week 3

Timeframe: Week 3

Trial details

NCT IDNCT04841408

SponsorUniversity Hospital, Bordeaux

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-01-31

View on ClinicalTrials.gov More Mycoplasma Genitalium Infection trials